Patient age is often a important Consider analyzing the eligibility of allo‐HSCT and the sort of conditioning regimen, The goal of the current stage IIb study was To guage the efficacy and security of tucidinostat in people with R/R ATLL. This is the initially analyze for sufferers with R/R intense https://clivej555ukw6.wikidank.com/user